Orphan Drug Approval in Canada, 1999-2022: A Cross-sectional Study

Joel Lexchin

Open source

DOI
10.34172/ijhpm.8916
Published
2025-09-28
Container
International Journal of Health Policy and Management
Publisher
Maad Rayan Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34172/ijhpm.8916,
  title = {Orphan Drug Approval in Canada, 1999-2022: A Cross-sectional Study},
  author = {Joel Lexchin},
  year = {2025},
  journal = {International Journal of Health Policy and Management},
  doi = {10.34172/ijhpm.8916},
  url = {https://doi.org/10.34172/ijhpm.8916}
}

RIS

TY  - JOUR
TI  - Orphan Drug Approval in Canada, 1999-2022: A Cross-sectional Study
AU  - Joel Lexchin
PY  - 2025
JO  - International Journal of Health Policy and Management
DO  - 10.34172/ijhpm.8916
UR  - https://doi.org/10.34172/ijhpm.8916
ER  - 

APA

Lexchin, J. (2025). Orphan Drug Approval in Canada, 1999-2022: A Cross-sectional Study. International Journal of Health Policy and Management. https://doi.org/10.34172/ijhpm.8916

Source records